Results presented here demonstrate our novel observation that pancreatic cancer cells become more sensitive to Ref-1 redox inhibition when PRDX1 expression is decreased and when RelA is present in the cells indicating a novel interplay between PRDX1, Ref-1, and RelA. This evidence concerns the gene APEX1 and pancreatic neoplasm.